Navigation Links
Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic

t of their workers out at one time.

The report mainly aims to target and alert the private sectors that accounts for 85 percent of all entities in the U.S., including banks, hospitals and food production.

‘While the pandemic will not damage power lines, banks or computer networks, it has the potential ultimately to threaten all critical infrastructure’ when people get sick and discontinue work ‘for weeks or months.’

Steve Brozak, an analyst at WBB Securities in Westfield, New Jersey has predicted that even government institutions might fail, at least temporarily, during a pandemic.

According to Brozak industries such as nursing homes and for-profit prisons would not be able to survive a pandemic in their present form and insurance companies could be irreparably harmed.

In the event of an outbreak, employers should substitute teleconferences for face-to-face meetings and adopt liberal leave policies for workers with sick family members to reduce the risk of disease transmission, the administration's report said.

Officials also urged maintaining a distance of three feet at work to reduce the risk of getting sick.

The Bush Administration also plans to have enough bird-flu vaccine stockpiled for 20 million people. Supplies of antiviral drugs for 75 million people to reduce the severity of the disease and limiting the spread of the disease was also planned.

The government plans to expand the number of poultry vaccines from 40 million to 110 million doses to protect the $29 billion U.S. industry.

Compensation for people harmed by experimental flu vaccines would increase under an amendment to a government spending bill proposed by Senator Edward Kennedy, a Massachusetts Democrat.

‘These funds would give the assurance needed to health professionals, first responders, and others who will be first to receive experimental flu vaccines that they will be compensated if they are in
'"/>




Page: 1 2 3

Related medicine news :

1. Study Unveils New Insight To The Madness Of King George III
2. Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development
3. Pesticides Linked to High Risk of Pediatric Cancers - a Study Unveils
4. Pet Owners Less Healthy: Study Unveils
5. Biocon Unveils Renal Therapies for Kidney Disorders
6. Latest device for identifying Melanomas
7. Latest discovery on Autism
8. Latest device for cardiac revival under test
9. Latest technique for asthma treatment
10. Latest drug shows promise in multiple myeloma
11. Latest Findings On The Deadly Disease - SARS
Post Your Comments:
(Date:12/5/2008)... RICHMOND HILL, ON, Dec. 5 /PRNewswire/ - Norgine,...pany, has today announced that it has granted Medi...P(R) in Canada. , MOVIPREP is a novel patent-pr...ansing prior to colonoscopy and other situations w...keted by Norgine in Europe and in the USA by its p...
(Date:12/5/2008)... BELLUS Health Receives NASDAQ Deficiency Notice R...--------------------------------------------------...ll/ - BELLUS Health Inc. (NASDAQ: BLUS ; TSX: BL...nt fluctuations in world capital markets, the Comp...SDAQ Capital Market, while continuing to maintain ...
(Date:12/5/2008)..., Dr. Alan Greene from th...ar milestone of eating only organic food. It,s the...tified 100% organic. , Da... animals can be certified organic by the Departmen...n and author Dr. Alan Greene, why not people?, , ,...
(Date:12/4/2008)..., Early detection of lung disease in cystic fibro...fants, may be the key to controlling the progressi...w research shows that contrary to previous scienti...s can begin as early as infancy even though lung f...e might be able to stop some of the lung function ...
Breaking Medicine News(10 mins):Health News:Medical Futures partners with Norgine for MOVIPREP(R) in Canada 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 3Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 2Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 3Health News:Intervention in infants with cystic fibrosis key to slowing progression 2Health News:Intervention in infants with cystic fibrosis key to slowing progression 3
...e WHO has issue a checklist for doctors and nurse ...s. Basic mistakes like not washing hands by the h...arters. The WHOs 9 solution is meant to improve p...essen the number of health care related accidents ...
...e Delhi High Court Wednesday held that the misuse ...taff would be viewed seriously, stressing that th...ision bench of Justice T.S. Thakur and Justice S.N... of the hospitals of both state and central govern...
...California-based Keralite doctor has bagged this y...the National Ethnic Coalition of Organisations (NE... award May 12, said he was "really delighted". "Th...o be a boost for all my future endeavours," Eapen ...
...ldiers returning from Iraq who have migraine heada...mptoms of post-traumatic stress, depression or anx...ording to research. The study involved 3,621 Unite...en a health screening questionnaire within 90 days...
Other Medicine News:Health News:UN Agencys Checklist on Health Care Error 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
(Date:12/3/2008)..., Dec. 3 Isogen, a contract develo...filling, announced it has retained a,strategic fi...et the global,biopharma demand for Isogen,s servi...ccessful first round series of capital,investment...y in Q1 2009 to,deliver on the previously unmet p...
(Date:12/3/2008)...Calif., Dec. 3 Bionovo, ...DA has reviewed the company,s,manufacturing and c...d,guidance on how Bionovo can move forward with t...for menopausal hot flashes. , "We have conc...moving to,address the Agency,s recommendations fo...
(Date:12/2/2008).... 3 Researchers using f...cuitry in the area of the brain,responsible for s...fering from,stress-related psychiatric disorders....the annual meeting of the Radiological Society of ... major depression and other stress-related disorde...
(Date:12/2/2008)...ass., Dec. 2 Biopure Cor...he U.S. Naval Medical Research Center,(NMRC) has ...) a revised,investigational new drug (IND) applic...s oxygen therapeutic Hemopure(R) [hemoglobin gluta...eld treatment of trauma patients. The study is,en...
Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3BrainCells Inc Completes 2430 Million Initial Closing of Series B Financing 3816 1BrainCells Inc Completes 2430 Million Initial Closing of Series B Financing 3816 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 1Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 3Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 4Sunesis Pharmaceuticals Reports Positive Interim Data for SNS 595 Single Agent Activity in Platinum Resistant Ovarian Cancer 1485 5Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 1Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 2Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 3Palatin Technologies Inc Reports Positive Results of a Phase I Clinical Study With PL 3994 for the Treatment of Congestive Heart Failure 3811 4Fralex reaches 100th patient milestone in fibromyalgia study 3810 1Fralex reaches 100th patient milestone in fibromyalgia study 3810 2Fralex reaches 100th patient milestone in fibromyalgia study 3810 3
...pril 2007. Giaconda Ltd (ASX: GIA) today,announced...s,approved the Company,s Investigational New Drug ...MyocondaR to treat patients with,Crohn,s Disease i...sis (MAP). , ,The Company understands that its lea...ubmitted to the FDA for this indication. There,are...
... 160th Annual Meeting of the American,Psychiatric ...-FirstCall/ -- In adults with,major depressive dis...py (ADT) resulted in significant improvement in th...ion Rating Scale (MADRS),Total Score. In this six-...ed here at the 160th Annual Meeting of the America...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material.
Table-mounted, retraction for radiolucent anterior spine procedures. Fully-adjustable for any approach and any patient. Combine with our radiolucent blade kit for optimal visibility.
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation.
Medicine Products: